Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **heme detoxification process in the parasite food vacuole** is essential for malaria parasites, particularly Plasmodium species, during their intraerythrocytic (within red blood cell) life stage. Here, the parasite ingests and degrades large quantities of host hemoglobin within a specialized lysosome-like organelle known as the digestive or food vacuole. Hemoglobin digestion releases free heme, which is highly toxic to the parasite. To prevent toxicity, the parasite rapidly converts free heme into an inert crystalline material called **hemozoin** through a biocrystallization process. This conversion is mediated by a multiprotein complex that includes proteases (such as falcipain 2, plasmepsins) and the **heme detoxification protein (HDP)**[2][6]. HDP is essential and highly potent for hemozoin formation, and the locus encoding HDP is refractory to genetic disruption, underscoring its vital role[2][6]. Many effective antimalarial drugs, including **chloroquine** and **artemisinin**, target this process by interfering with hemozoin formation in the food vacuole, causing accumulation of toxic heme and leading to parasite death[2][3][6]. Resistance to these drugs is a major concern for malaria control. The exact biochemistry of heme biocrystallization is still not fully understood, but disruption of this pathway is considered a “weakest link” in the malaria parasite lifecycle, making it a premier therapeutic target[2][4][6]. **Note:** - “Heme detoxification process in parasite food vacuole” is not a single molecular entity but a multiprotein process/pathway. The central protein, heme detoxification protein (HDP), is the most specific targetable molecule, but the process also includes key proteases and other factors[2][6][4]. - This entry should be normalized to specific proteins or well-defined complexes for structured databases. - The current query describes a *process*, not a single canonical molecule; thus, treat as a polyprotein/multiprotein pathway with HDP as core target.
Inhibition of hemozoin (Hz) formation; Disruption of hemoglobin digestion–heme detoxification coupling; Drug–heme binding, which prevents polymerization into Hz
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme detoxification protein (HDP)–hemoglobin degradation–hemozoin formation process in parasite food vacuole (HDP).